Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 2
1956 2
1957 1
1958 1
1959 1
1961 10
1962 9
1963 10
1964 12
1965 13
1966 16
1967 8
1968 24
1969 13
1970 12
1971 5
1972 8
1973 10
1974 20
1975 14
1976 20
1977 11
1978 14
1979 15
1980 11
1981 26
1982 35
1983 35
1984 24
1985 43
1986 49
1987 56
1988 58
1989 81
1990 75
1991 67
1992 80
1993 93
1994 92
1995 101
1996 80
1997 63
1998 73
1999 78
2000 67
2001 79
2002 90
2003 80
2004 81
2005 78
2006 101
2007 92
2008 96
2009 106
2010 114
2011 83
2012 82
2013 80
2014 86
2015 89
2016 95
2017 101
2018 104
2019 110
2020 142
2021 171
2022 180
2023 159
2024 90

Text availability

Article attribute

Article type

Publication date

Search Results

3,736 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Asaoka D, Xiao J, Takeda T, Yanagisawa N, Yamazaki T, Matsubara Y, Sugiyama H, Endo N, Higa M, Kasanuki K, Ichimiya Y, Koido S, Ohno K, Bernier F, Katsumata N, Nagahara A, Arai H, Ohkusa T, Sato N. Asaoka D, et al. Among authors: takeda t. J Alzheimers Dis. 2022;88(1):75-95. doi: 10.3233/JAD-220148. J Alzheimers Dis. 2022. PMID: 35570493 Free PMC article. Clinical Trial.
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
Kawachi H, Yamada T, Tamiya M, Negi Y, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Ishida M, Katayama Y, Morimoto K, Iwasaku M, Tokuda S, Kijima T, Takayama K. Kawachi H, et al. Among authors: takeda t. JAMA Netw Open. 2023 Jul 3;6(7):e2322915. doi: 10.1001/jamanetworkopen.2023.22915. JAMA Netw Open. 2023. PMID: 37432682 Free PMC article.
Chemotherapy for Biliary Tract Cancer in 2021.
Sasaki T, Takeda T, Okamoto T, Ozaka M, Sasahira N. Sasaki T, et al. Among authors: takeda t. J Clin Med. 2021 Jul 14;10(14):3108. doi: 10.3390/jcm10143108. J Clin Med. 2021. PMID: 34300274 Free PMC article. Review.
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
Katayama Y, Yamada T, Tanimura K, Tokuda S, Morimoto K, Hirai S, Matsui Y, Nakamura R, Ishida M, Kawachi H, Yoneda K, Hosoya K, Tsuji T, Ozasa H, Yoshimura A, Iwasaku M, Kim YH, Horinaka M, Sakai T, Utsumi T, Shiotsu S, Takeda T, Katayama R, Takayama K. Katayama Y, et al. Among authors: takeda t. NPJ Precis Oncol. 2023 Jan 26;7(1):12. doi: 10.1038/s41698-023-00350-7. NPJ Precis Oncol. 2023. PMID: 36702855 Free PMC article.
A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses.
Kim JK, Jha NN, Awano T, Caine C, Gollapalli K, Welby E, Kim SS, Fuentes-Moliz A, Wang X, Feng Z, Sera F, Takeda T, Homma S, Ko CP, Tabares L, Ebert AD, Rich MM, Monani UR. Kim JK, et al. Among authors: takeda t. Neuron. 2023 May 3;111(9):1423-1439.e4. doi: 10.1016/j.neuron.2023.02.004. Epub 2023 Mar 1. Neuron. 2023. PMID: 36863345 Free PMC article.
3,736 results